IVISbrite™ Staphylococcus aureus Xen36 bioluminescent bacteria was derived from a parental strain from the American Type Culture Collection (ATCC), used under license. For in vitro or in vivo imaging applications, IVISbrite S. aureus-Xen36 possesses a stable copy of the Photorhabdus luminescens lux operon on the native plasmid.
For research use only. Not for use in diagnostic procedures.
For research use only. Not for use in diagnostic procedures.
Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. Our bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:
Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:
Brand |
IVISbrite
|
---|---|
Gram Positive Gram Negative |
Gram positive
|
Imaging Modality |
Bioluminenscence
|
Luciferase Classification |
Bacterial luciferase
|
Optical Imaging Classification |
Bioluminescence Imaging
|
Shipping Conditions |
Shipped Ambient
|
Therapeutic Area |
Infectious Diseases
|
Unit Size |
1 agar plate
|
Bacteria growth preparation guidelines using Revvity's IVISbrite™ lux operon labeled bioluminescent bacteria designed for in vivo...
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
We are here to answer your questions.